Serotonergic System and Violent Video Games
Serogen
Genetic-pharmacological Neuroimaging of the Serotonergic System in Violent Video Games
1 other identifier
interventional
47
1 country
1
Brief Summary
Aggressive behavior (AB) is a major burden to society with severe socio-economic consequences. Genetic studies suggest a high heritability of AB; in particular, the low expressing allele of the MAOA gene (MAOA-L) has been associated with increased AB. Recent neural aggression models have suggested a dysfunctional emotion regulation circuit including amygdala, orbitofrontal, and anterior cingulate cortex. Dysregulated serotonergic (5-HT) projections from the anterior cingulate cortex to the amygdala have been suggested to promote aggressive behavior. This finding is well in line with the observation that the MAOA-L allele leads to a reduced expression of monoamine oxidase A and thus to an overflow of 5-HT in serotonergic cortico-amygdalar projections. However, due to methodological and ethical constraints, the neural substrates of AB are difficult to assess. A possible solution is the use of virtual violence which permits AB against virtual characters without direct consequences for any real person and can be easily applied in functional imaging experiments. There is evidence that virtual and real aggression share common neural substrates. AB in violent video games inhibits rostral anterior cingulate cortex (ACC) and amygdala in line with the suggested neurophysiological circuits underlying real-life AB.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Feb 2012
Longer than P75 for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 20, 2012
CompletedFirst Posted
Study publicly available on registry
July 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedSeptember 29, 2015
September 1, 2015
2 years
June 20, 2012
September 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
functional neuroimaging
1 day
Study Arms (1)
arm 1
EXPERIMENTALapplication of three treatments and three masurements within 3 weeks
Interventions
Eligibility Criteria
You may qualify if:
- male
- age 18-60 (adults), age 12-17 (juveniles)
- right-handedness
- German native language
You may not qualify if:
- any contraindications against MR investigations
- any contraindications against application of SSRIs
- any history of neurological or psychiatric illness
- history of drug abuse
- history of psychopharmacological therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Aachen
Aachen, 52074, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2012
First Posted
July 18, 2012
Study Start
February 1, 2012
Primary Completion
February 1, 2014
Study Completion
June 1, 2014
Last Updated
September 29, 2015
Record last verified: 2015-09